Xenon Pharmaceuticals Inc (XENE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,514 | -7,659 | -7,484 | -41,595 | -30,219 |
| Depreciation Amortization | 658 | 487 | 241 | 954 | 671 |
| Income taxes - deferred | -240 | -52 | 52 | -133 | -73 |
| Accounts receivable | -827 | -1,009 | -824 | -653 | -54 |
| Other Working Capital | -23,290 | -19,598 | -7,132 | 33,520 | 3,848 |
| Other Operating Activity | 5,203 | 3,975 | 2,080 | 3,193 | 1,326 |
| Operating Cash Flow | $-35,010 | $-23,856 | $-13,067 | $-4,714 | $-24,501 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -58,214 | -40,975 | -52,278 | -64,969 | -5,246 |
| PPE Investments | -1,809 | -1,016 | -647 | -1,240 | -645 |
| Investing Cash Flow | $-60,023 | $-41,991 | $-52,925 | $-66,209 | $-5,891 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -16,743 | -16,743 | N/A | N/A | N/A |
| Common Stock Issued | 102,493 | 102,493 | 102,470 | 27,518 | 87 |
| Financing Cash Flow | $85,750 | $85,750 | $102,470 | $27,518 | $87 |
| Exchange Rate Effect | -372 | -459 | -725 | 406 | 222 |
| Beginning Cash Position | 24,755 | 24,755 | 24,755 | 67,754 | 67,754 |
| End Cash Position | 15,100 | 44,199 | 60,508 | 24,755 | 37,671 |
| Net Cash Flow | $-9,655 | $19,444 | $35,753 | $-42,999 | $-30,083 |
| Free Cash Flow | |||||
| Operating Cash Flow | -35,010 | -23,856 | -13,067 | -4,714 | -24,501 |
| Capital Expenditure | -1,809 | -1,016 | -647 | -1,240 | -645 |
| Free Cash Flow | -36,819 | -24,872 | -13,714 | -5,954 | -25,146 |